Colin Clancy | Senior Director of Investor Relations |
Eric Adams | President and Chief Executive Officer |
Bruce Colwill | Chief Financial Officer |
Eric Hsu | Senior Vice President, Preclinical Research and Development |
Alexandra Mancini | Senior Vice President, Clinical and Regulatory Affairs |
Michael Woudenberg | Vice President, Chemistry, Manufacturing and Control |
Scott Henry | ROTH capital Partners |
Max Jacobs | Edison Investment Research |
Thank you for standing by and welcome to the InMed Pharmaceuticals Inc. Fourth Quarter Fiscal 2021 Financial Results and Business Update. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions].